发明公开
EP0758312A1 SUBSTITUTED FUSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
失效
取代的稠合和桥双环化合物作为治疗剂
- 专利标题： SUBSTITUTED FUSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
- 专利标题（中）： 取代的稠合和桥双环化合物作为治疗剂
-
申请号： EP95913699.0申请日： 1995-03-15
-
公开(公告)号： EP0758312A1公开(公告)日： 1997-02-19
- 发明人: HU, Hong , JAGDMANN, G., Erik, Jr. , MENDOZA, Jose, Serafin
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 代理机构： Hudson, Christopher Mark
- 优先权： US19940237645 19940504; US19950392710 19950223
- 国际公布： WO1995030640 19951116
- 主分类号： C07D451
- IPC分类号： C07D451 ; A61K31 ; A61P3 ; A61P9 ; A61P25 ; A61P29 ; A61P31 ; A61P35 ; A61P43 ; C07C69 ; C07C235 ; C07D471
摘要：
Compounds having formula (I) are useful as inhibitors of protein kinase C. Also disclosed are pharmaceutical compositions including such compounds.
信息查询
